Pulmonology clinical trials recruiting in California

90 recruiting pulmonology trials match in California. Showing 20.

• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Recruiting

  Phase 3 · Generate Biomedicines · Bakersfield, California

• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRecruiting

  Phase 2 · AstraZeneca · Los Angeles, California

• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningRecruiting

  N/A · Freenome Holdings Inc. · Los Angeles, California

• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  Phase 2 · Cumberland Pharmaceuticals · La Mesa, California

• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruiting

  Phase 2 · Eli Lilly and Company · Newport Beach, California

• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruiting

  Phase 2 · InSilico Medicine Hong Kong Limited · Los Angeles, California

• STRIVE Post-Market Registry StudyRecruiting

  N/A · Olympus Corporation of the Americas · Mountain View, California

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Recruiting

  Phase 3 · AstraZeneca · Los Angeles, California

• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDRecruiting

  Phase 2 · Johns Hopkins University · Baltimore, Maryland

• Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD OverlapRecruiting

  N/A · Gelb, Arthur F., M.D. · Lakewood, California

• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Recruiting

  Phase 2 · Deciphera Pharmaceuticals, LLC · Duarte, California

• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruiting

  Phase 3 · GlaxoSmithKline · Bakersfield, California

• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting

  N/A · Duke University · Palo Alto, California

• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With AsthmaRecruiting

  Phase 2 · AstraZeneca · Bakersfield, California

• Phase 2 Study to Assess the Safety and Efficacy of ANG003Recruiting

  Phase 2 · Anagram Therapeutics, Inc. · Long Beach, California

• Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and EndotypingRecruiting

  Phase 4 · University of California, San Diego · La Jolla, California

• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentRecruiting

  Phase 3 · AstraZeneca · Inglewood, California

• Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting

  N/A · Gelb, Arthur F., M.D. · Lakewood, California

• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastRecruiting

  Phase 3 · Boehringer Ingelheim · Sacramento, California

• Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside StudyRecruiting

  Phase 4 · Chris Goss · La Jolla, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.